Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Latest R&D Spending Benchmark Study Puts Cancer Drug Costs At $648M

Executive Summary

Estimate in JAMA paper is significantly lower than often-cited $2.6bn in research and development costs projected in a 2014 study by Tufts Center for the Study of Drug Development.

Advertisement

Related Content

FDA's Gottlieb Pushing 'Seamless' Clinical Trials For Faster Development
Why Is Drug Pricing Higher In US? Study Takes Aim At R&D Argument
Cost Of New Drug Development Pushed To $2.6 Bil. By High Failure Rate – Study

Topics

Advertisement
UsernamePublicRestriction

Register

PS121511

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel